Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Arquer Diagnostics logo — Leading the way in non-invasive tests for diagnosing and mon...

Arquer Diagnostics

Leading the way in non-invasive tests for diagnosing and monitoring cancer.

Founded 2006 United Kingdom Sunderland, United Kingdom 3 employees Convertible Note Total: $8.48M Biotechnology, Health Care +1

General Information

Company Name Arquer Diagnostics
Founded Year 2006
Location United Kingdom Sunderland, United Kingdom +1
Employees 3
Industries Biotechnology, Health Care, Medical Devices
Funding Stage Convertible Note
Social

Get notified when Arquer Diagnostics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Arquer Diagnostics

Arquer Diagnostics is a biotechnology startup that specializes in the healthcare industry. Founded in 2006, the company recently secured a £2.49M Convertible Note investment on 24 March 2022. The investment came from Northstar Ventures, a noteworthy investor in the startup space. With a focus on biotechnology and healthcare, Arquer Diagnostics is positioned to make impactful contributions to the medical field.

Funding Rounds & Investors (8)

View All
Funding Stage Amount Investors Lead Investors Date
Convertible Note •••••• 1
Investor
24 Mar 2022
Series B •••••• 1
Investor
20 Mar 2019
Series B •••••• 2
Investor Investor
03 Oct 2017
Grant •••••• 1
Investor
01 Mar 2017
Venture Round •••••• 4
Investor Investor Investor Investor
16 Jan 2015

View All 8 Funding Rounds

Arquer Diagnostics Alternatives & Competitors

Arquer Diagnostics vs
Wren Laboratories
Wren Laboratories United States

Unleashing the Power of mRNA and AI for Cancer Diagnostics

25 employees
Biotechnology, Health Care
Arquer Diagnostics vs
Geneseq Biosciences
Geneseq Biosciences Australia

Breakthrough tests for early and accurate cancer diagnosis, treatment response prediction and diseas...

2 employees
Arquer Diagnostics vs
Glycanostics
Glycanostics Slovakia

Our patented technology for screening cancers detects changes in a glycan attached to proteins in th...

20 employees

FAQ About Arquer Diagnostics

Leading the way in non-invasive tests for diagnosing and monitoring cancer.
Arquer Diagnostics was founded in 2006.
Arquer Diagnostics is headquartered in Sunderland, United Kingdom.
Arquer Diagnostics operates in the following industries: Biotechnology, Health Care, Medical Devices.
Arquer Diagnostics has approximately 3 employees.
Arquer Diagnostics has completed 8 funding rounds, raising a total of $8.48M. The latest funding stage is Convertible Note.
Top alternatives and competitors to Arquer Diagnostics include Wren Laboratories, Geneseq Biosciences, Glycanostics, Surfix, GenoME Diagnostics Ltd. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Arquer Diagnostics and Wren Laboratories are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Arquer Diagnostics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy